ÂÜÀòÂÒÂ×

Christina Lindenboom joined Alnylam in 2015 and serves as Senior Vice President, Investor Relations and Corporate Communications, leading a multidisciplinary team responsible for external & internal communication, corporate responsibility, brand and creative and investor relations. Before joining Alnylam, Christine served as Senior Director, Corporate Communications at Pfizer where she supported internal and external communications for R&D, and also served in various roles in media relations. Prior to that, she led corporate media relations for Amgen supporting tax, litigation, finance and M&A. Previously at Amgen she led communication for the oncology therapeutics franchise and led launch communications for XGEVA. Prior to joining Amgen, she worked at Fleishman Hillard supporting various pharmaceutical and biotech clients, and she started her career in the communications group of Millennium Pharmaceuticals.

Christine graduated from Northeastern University in Boston.